Reverse Logistics
AMAX reverse logistics solutions provide global visibility, operational scalability, flexibility and control. For customers, this means AMAX goes beyond processing returned products. By participating in the AMAX RMA Program, you are assured that any trouble with a system is solved with minimal downtime.
AMAX also provides reconditioning and remanufacturing services. Our comprehensive process includes aesthetically refurbishing the unit, reconditioning, retesting and reimaging to MPI specifications, replacing missing accessories and documentation, thus ensuring the unit is repacked to new standards and ready to ship. These programs are customized to your unique requirements and specifications. Our goal is to make certain your product is restored to a "like-new" condition.
AMAX reverse solutions offers full RMA refurbishing for evaluation machines from OEM customers who have an Evaluation Program with their customers, and any trial system shipped back for refurbishment is properly restored, tested, imaged and returned to stock.
AMAX understands the reverse-product life cycle process and can deliver customer satisfaction, management and operational control. Through continuous process improvements, we have designed best practices in reverse logistics that recover assets and uncover hidden value for our customers. Our refurbishment process restores evaluation systems to like-new condition, extending the system life cycle, which ensures that your customers will always receive products with all appropriate accessories, documentation, and packaging that is representative of new product.
|
|
Previous: Logistics
|
Next: Global Warranty Coverage
|
|
|
| Questions? |
|
|
|
Call 1.800.800.6328
|
|
|
|
|
|
| Testimonial |
"As a result of the AMAX solutions, doctors and radiologists have tripled and even quadrupled the number of patients they see using medical devices operated by systems built by AMAX. AMAX's leading-edge technologies help keep us ahead in this market, meaning better, less invasive and faster treatment for patients around the world."
- Executive for Research and Development, Boston Scientific |
|
|
 |
|
